Literature DB >> 15140581

Genetic association analysis of myocardial infarction with thrombospondin-1 N700S variant in a Chinese population.

Xiaoyang Zhou1, Jianfeng Huang, Jianhong Chen, Jiangong Zhao, Dongliang Ge, Wenjie Yang, Dongfeng Gu.   

Abstract

INTRODUCTION: Thrombospondin-1 (TSP-1) is very important in platelet adhesion and aggregation, inflammation, cell to cell interaction, and vascular smooth muscle cell proliferation. Therefore, it may play an important role in the progression of cardiovascular disease. Recently, the TSP-1 N700S variant was proposed to be a new genetic predictor for myocardial infarction (MI) in American population, but the hypothesis was not verified in two other populations. We investigated a possible association between the N700S polymorphism and MI in a Chinese Han population.
MATERIALS AND METHODS: We performed a case-control study including 406 patients who survived an acute MI before age 60 years and 400 age- and sex-matched controls. The N700S polymorphism was determined by polymerase chain reaction and restriction fragment length polymorphism.
RESULTS: Of the 806 subjects participating in the study, only 7 of the heterozygotes and none of the homozygotes were detected for the 700S allele. The prevalence of the S allele in the healthy controls was less frequent than those of the west populations (0.3% vs. 11%). No association of the N700S polymorphism with an altered risk of MI was found in our study (GA vs. AA: OR=2.48; 95% CI, 0.48 to 12.86; P=0.46).
CONCLUSIONS: Our study suggested that the TSP-1 N700S polymorphism was rare and unrelated to MI in the Chinese Han population. Additional investigations should be performed in populations at different risk for coronary events in order to further elucidate the possible contribution of the polymorphism to cardiovascular disease. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140581     DOI: 10.1016/j.thromres.2004.02.016

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

1.  The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size.

Authors:  Jeffrey I Zwicker; Flora Peyvandi; Roberta Palla; Rossana Lombardi; Maria Teresa Canciani; Andrea Cairo; Diego Ardissino; Luisa Bernardinelli; Kenneth A Bauer; Jack Lawler; Pier Mannucci
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

Review 2.  Thrombospondin-1 Signaling Through the Calreticulin/LDL Receptor Related Protein 1 Axis: Functions and Possible Roles in Glaucoma.

Authors:  Joanne E Murphy-Ullrich
Journal:  Front Cell Dev Biol       Date:  2022-05-27

Review 3.  Thrombospondin-1 in maladaptive aging responses: a concept whose time has come.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-06       Impact factor: 4.249

Review 4.  Molecular genetics of atherosclerosis.

Authors:  Himadri Roy; Shalini Bhardwaj; Seppo Yla-Herttuala
Journal:  Hum Genet       Date:  2009-03-20       Impact factor: 4.132

Review 5.  Thrombospondins: A Role in Cardiovascular Disease.

Authors:  Dimitry A Chistiakov; Alexandra A Melnichenko; Veronika A Myasoedova; Andrey V Grechko; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2017-07-17       Impact factor: 5.923

6.  The brominated compound aeroplysinin-1 inhibits proliferation and the expression of key pro- inflammatory molecules in human endothelial and monocyte cells.

Authors:  Beatriz Martínez-Poveda; Javier A García-Vilas; Casimiro Cárdenas; Esther Melgarejo; Ana R Quesada; Miguel A Medina
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

7.  Identification of Missense Extracellular Matrix Gene Variants in a Large Glaucoma Pedigree and Investigation of the N700S Thrombospondin-1 Variant in Normal and Glaucomatous Trabecular Meshwork Cells.

Authors:  Mary K Wirtz; Renee Sykes; John Samples; Beth Edmunds; Dongseok Choi; Douglas R Keene; Sara F Tufa; Ying Ying Sun; Kate E Keller
Journal:  Curr Eye Res       Date:  2021-07-06       Impact factor: 2.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.